Home / Resource Library / Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma

Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma

Results of a study investigating ruxolitnib for treatment of relapsed Hodgkin and PMBCL.